Haemonetics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Haemonetics Corporation inventory turnover ratio, the Haemonetics Corporation's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.68 in the first quarter 2026, yet the ratio remained below the average, as HAE's market remain challenging.Average inventory processing period, for the Haemonetics in Jun 27 2026 quarter, has decreased to 217 days, compare to 228 days, in the Mar 28 2026 quarter.

Within Healthcare sector 234 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1462 in the fourth quarter 2026, to 1661.

HAE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Haemonetics Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HAE Inventory Turnover Ratio	(Jun 27 2026) I. Quarter	(Mar 28 2026) IV. Quarter	(Dec 27 2025) III. Quarter	(Sep 27 2025) II. Quarter	(Jun 28 2025) I. Quarter
Y / Y Inventory Growth	-14.92 %	-16.1 %	15.11 %	-12.01 %	-3.55 %
Y / Y Cost of Sales Growth	5.87 %	7.97 %	-11.69 %	-16.46 %	-19.88 %
Inventory Turnover Ratio (TTM)	1.68	1.6	1.5	1.6	1.63
HAE's Total Ranking	# 1661	# 1462	# 1177	# 726	# 1110
Average inventory processing period	217	229	243	228	225
Seq. Inventory Growth	0.12 %	-16.1 %	8.61 %	-6.75 %	-1.26 %
Seq. Cost of Sales Growth	-8.34 %	9.56 %	3.03 %	2.33 %	-6.52 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 104
Healthcare Sector	# 235
Overall Market	# 1661

Inventory Turnover Ratio Statistics
High	Average	Low
3.24	2.18	1.5
(Dec 29 2018)		(Dec 27 2025)

HAE Company Profile >> Back to HAE Efficiency Comparisons >> Compare HAE Inventory Turnover Ratio to its Competitors

Financial Statements
Haemonetics's Inventories	$ 307 Millions	Visit HAE's Balance sheet
Haemonetics's Cost of Revenues TTM	$ 554 Millions	Visit HAE's Income Statement
What are HAE's Sales?		Visit HAE's Sales by Segment

Other Inventory Turnover Ratios
Haemonetics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HAE's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HAE's Competitors
Inventory Turnover Ratio for HAE's Suppliers
Inventory Turnover Ratio for HAE's Customers

You may also want to know
HAE's Sales Growth Rates	HAE's Pe Price to earnings ratio	HAE's Receivables Turnover Ratio	HAE's Stock Quote
HAE's Net Income Growth Rates	HAE's Ps Price to Sales ratio	HAE's Sales per Employee	HAE's Asset Turnover Ratio
HAE's Net Margin	HAE's Pb Price to Book ratio	HAE's Financial Strength Ratios	HAE's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 27 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 27 2026	Inventories at quarter ending Jun 27 2026
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Ufp Technologies Inc	4.93	$ 452.046 Millions	$ 92 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions

Date modified: 2026-09-05T15:12:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.